Turn Therapeutics Inc.
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
TTRX$9.92+1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
| (a) | During the period covered by this Quarterly Report, we issued 165,000 shares of our common stock to certain accredited investors at a price of $10 per share for gross proceeds of $1,650,000. The shares of common stock issued to accredited shareholders were issued in reliance upon an exemption from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act and no underwriting fees were paid for sale of these shares. |
| (b) | Not applicable. |
| (c) | None. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.